Abstract
Zinc is essential for the growth and development of all organisms. The first observations were made by Raulin in 1869 (1), who described the need for zinc in cultivating Aspergillus niger. In 1934, Todd et al. showed the importance of zinc in mammals by establishing a rat model (2). Later, a zinc deficiency syndrome in children was described by Prasad et al. in 1963 (3). These children suffered from anemia, hypogonadism, hepatosplenomegaly, skin alterations, growth, and mental retardation. Then, it was shown that these symptoms occurred because of zinc deficiency resulting from a zinc-specific malabsorption syndrome called Acrodermatitis enteropathica (a rare autosomal recessive inheritable disease), which was discovered by Neldner and Hambidge in 1975 (4). Acrodermatitis enteropathica leads to death within a few years when it is untreated, because it shows several immunologic alterations and a high frequency of bacterial, viral, and fungal infections. However, pharmacologic zinc supplementation can reverse all of the disease’s symptoms (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Raulin J. Etudes Chimique sur al vegetation (chemical studies on plants). Annales des Sciences Naturelles Botanique et Biologie Vegetale 1869;11:293–299.
Todd WK, Evelym A, Hart EB. Zinc in the nutrition of the rat. Am J Physiol 1934;107:146–156.
Prasad AS, Miaie A Jr, Farid Z, Schulert A, Sandsteadt HH. Zinc metabolism in patients with the syndrome of iron deficiency, hypogonadism and dwarfism. J Lab Clin Med 1963;83:537–549.
Neldner KH, Hambidge KM. Zinc therapy in acroderamtitis enteropathica. N Engl J Med 1975;292: 879–882.
Mills CF. Zinc in human biology. Hum Nutr Rev 1989;4:1–381.
Favier A, Favier M. Consequences des deficits en zinc durant la grossesse pour la mere et le nouveau ne. Rev Fr Gynecol Obest 1990;85:13–27.
Scott BJ, Bradwell AR. Identification of the serum binding proteins for iron, zinc, cadmium, nickel and calcium. Clin Chem 1983;29:629–633.
Krebs NF, Hambidge KM. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals 2001;14:397–412.
Outten CE, O’Halloran TV. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science 2001;292:2488–2492.
Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistence to infections. Am J Clin Nutr 1998;68:447S-463S.
Thompson RB, Walt DR. Emerging strategies for molecular biosensors. Naval Res Rev 1994;46:19–29.
Fierke CA, Thompson RB. Fluorescence-based biosensing of zinc using carbonic anhydrase. Biometals 2001;14:205–222.
Andrews GK. Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals 2001;14: 223–237.
Kagi JHR, Schaffer A. Biochemistry of metallothionein. Biochemistry 1988;27:8509–8515.
Palmiter RD, Findley SD. Cloning and functional characterization of mammalian zinc transporter that confers resistence to zinc. EMBO J 1995;14:639–649.
Griffith OW, Mulcahy RT. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthtase. Adv Enzymol Relat Areas Mol Biol 1999;73:209–267.
Lu SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 1999;13:1169–1183.
Ballatori M. Glutathione mercaptides as transport forms of metals. Adv Pharmacol 1994;27:271–298.
Bittel D, Daltion T, Samson SL, Gedamu L, Andrews GK. The DNA binding activity of metal resonse element-binding transcription factor-1 is activated in vivo and in vitro by zinc, but not by other transition metals. J Biol Chem 1998;273:7123–7133.
Smirnova IV, Bittel, Ravindra R, Jiang H, Andrews GK. Zinc and cadmium can promote rapid response element-binding transcription factor-1. J Biol Chem 2000;275:9377–9384.
Gaither LA, Eide DJ. Eukaryotic zinc transporters and their regulation. Biometals 2001;14:251–270.
Kobayashi T, Beuchat M, Lindsay M, et al. Late endosomal membranes rich in lysobiphosphatidic acid regulate cholesterol transport. Nature Cell Biol 1999;1:113–118.
Palmiter RD, Cole TB, Findley SD. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J 1996;15:1784–1791.
Palmiter RD, Cole TB, Quiafe CJ, Findley SD. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci USA 1996;93:14934–14939.
Huang L, Gitschier J. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nature Genet 1997;17:292–297.
Murgia C, Vespignani I, Cerase J, Nobili F, Perozzi G. Cloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cells. Am J Physiol 1999;277:G1231-G1239.
Eide D, Broderius M, Fett J, Guerinot ML. A novel iron-regulated metal transporter from plants identified by functional expression in yeast. Proc Natl Acad Sci USA 1996;93:5624–5628.
Zaoh H, Eide D. The yeast ZRT1 gene encodes the zinc transporter of a high affinity uptake system induced by zinc limitation. Proc Natl Acad Sci USA 1996;93:2454–2458.
Cao J, Jeffrey AB, Luzzi JP, Cousins RJ. Effects of intracellular zinc depletion on metallothionein and ZIP2 transporter expression and apoptosis. J Leuk Biol 2001;70:559–566.
Gaither LA, Eide DJ. Functional characterization of the human hZIP2 zinc transporter. J Biol Chem 2000;275:5560–5564.
Gaither LA, Eide DJ. The human ZIP1 transporter mediates zinc uptake in human K562 erythroleuke-mia cells. J Biol Chem 2001;276:22258–22264.
Bentley PJ. Influx of zinc by channel catfish (Ictalurus punctatus): uptake from external environmental solutions. Comp Biochem Physiol C 1992;101:215–217.
Hogstrand C, Verbost PM, Bonga SE, Wood CM. Mechanisms of zinc uptake in gills of freshwater rainbow trout interplay with calcium transport. Am J Physiol 1996;270:R1141-R1147.
Wellinghausen N, Fischer A, Kirchner H, Rink L. Interaction of zinc ions with human peripheral blood mononuclear cells. Cell Immunol 1996;171:255–261.
Rink L, Gabriel P. Zinc and the immune system. Proc Nutr Soc 2000;59:541–552.
Coleman JE. Zinc proteins: enzymes, storage proteins, transcription factors and replications proteins. Annu Rev Biochem 1992;16:897–946.
Valle BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993;73:79–118.
Auld DS. Zinc coordination sphere in biochemial zinc sites. Biometals 2001;14:271–313.
Fraser JD, Urban RG, Strominger JL, Robinson H. Zinc regulates the function of two superantigens. Proc Natl Acad Sci USA 1992;89:5507–5511.
Bernatchez C, Al-Daccak R, Mayer PE, et al. Functional analysis of Mycoplasma arthritidis-derived mitogen interaction with class II molecules. Infect Immunol 1997;65:2000–2005.
Trung-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals 2001;14:315–330.
Zalewski PD, Frobes IJ. Intracellular zinc and the regulation of apoptosis. In: Lavin M, Watters D (eds.). Programmed Cell Death: The Cellular and Molecular Biology of Apoptosis. Harwood Academic Publishers, Melbourne, 1993, pp. 73–86.
Zalewski PD, Forbes IJ, Giannakis C. Physiological role for zinc in prevention of apoptosis (genedirected death). Biochem Int 1991;24:1093–1101.
Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn (II) Zn, using zinquin, a new specific fluorescent probe for Zn (II). Biochem J 1993;296:403–408.
Treves S, Trentini PL, Ascanelli M, Bucci G, Di Virgilio F. Apoptosis is dependent on intracellular zinc and independent of intracellular calcium in lymphocytes. Exp Cell Res 1994;211:339–343.
Toung-Tran AQ, Ho LH, Chai F, Zalewski PD. Cellular zinc fluxes and the regulation of apoptosis/ gene-directed cell death. J Nutr 2000;130(Suppl):1459S-1466S.
Chai F, Tuong-Tran AQ, Evdokiou A, Young GP, Zalewski PD. Intracellular zinc depletion induces caspase activation and p21 W afl/Ci p 1 cleavage in human epithelial cell lines. J Infect Dis 2000;182: S85-S92.
Meerarani P, Ramadass P, Toborek M, Bauer HC, Bauer H, Hennig B. Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor alpha. Am J Clin Nutr 2000;71: 81–87.
Matsushita K, Kitagawa K, Matsuyama T, et al. Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. Brain Res 1996;743:362–365.
Kuo IC, Seitz B, LaBree L, McDonnell PJ. Can zinc prevent apoptosis of anterior keratocytes after superficial keratectomy? Cornea 1997;16:550–555.
Kown MH, Van Der Steenhoven T, Blankenberg FG, et al. Zinc-mediated reduction of apoptosis in cardiac allografts. Circulation 2000;102(Suppl 3):228–232.
Bettger WJ, O’Dell BL. A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 1981;28:1425–1438.
Powell SR. The antioxidant properties of zinc. J Nutr 2000;130:14475–14545.
Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000;10:649–655.
Nakatani T, Tawaramoto M, Kennedy D, Kojima A, Matsui-Yuasa I. Apoptosis induced by chelation of intracellular zinc is associated with depletion of cellular reduced glutathione level in rat hepatocytes. Chem Biol Interact 2000;125:151–163.
Maret W, Vallee BL, Fischer EH. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc Natl Acad Sci USA 1999;96:1936–1940.
Takahashi A, Alnemri ES, Lazebnik YA, et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 1996;93:8395–8400.
Stennicke HR, Salvesen GS. Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem 1997;272:25719–25723.
Mesner PW, Bible KC, Martins LM, et al. Characterization of caspase processing and activation in HL60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profile. J Biol Chem 1999;274:22635–22645.
Wolf CM, Eastman A. The temporal relationship between protein phosphatase, mitochondrial cytochrome c release, and caspase activation in apoptosis. Exp Cell Res 1999;247:505–513.
Fukamachi Y, Karasaki Y, Sugiura T, et al. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of Bcl-2/Bax ratio. Biochem Biophys Res Comm 1998;246:364–369.
Flieger D, Riethmuller G, Ziegler-Heitbrock HW. Zn++ inhibits both tumor necrosis factor-mediated DNA fragmentation and cytolysis. Int J Cancer 1989;44:315–319.
Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 2001:14:331–341.
Francis SH, Colbran JL, McAllister-Lucas LM, Corbin JD. Zinc interactions and conserved motifs of the cGMP-binding cGMP specific phosphodiesterase suggest that it is a zinc hydrolase. J Biol Chem 1994;269:22477–22480.
Percival MD, Yeh B, Falgueyret JP. Zinc dependent activation of cAMP-specific phosphodiesterase (PDE4A). Biochem Biophys Res Comm 1997;241:175–180.
He F, Seryshev AB, Cowan CW, Wensel TG. Multiple zinc binding sites in retinal rod cGMP phosphodiesterase, PDE6ab. J Biol Chem 2000;20752–20577.
Waetjen W, Benters J, Haase H, Schwede F, Jastorff B, Beyersmann D. Zn2+ and Cd2+ increase the cyclic GMP level in PC 12 cells by inhibition of the cyclic nucleotide phosphodiesterase. Toxicology 2001;157:167–175.
Haase H. Zinkhomöostase in Saugerzellen: Untersuchungen zur Aufnahme, intrazellulären Verteilung und Toxizität. GCA-Verlag, Herdecke, Germany 2001.
Csermely P, Szamel M, Resch K, Somogyi J. Zinc can increase the activity of protein kinase C and contributes to its binding to the plasma membrane in T lymphocytes. J Biol Chem 1988;263:6487–6490.
Zalewski PD, Forbes IJ, Giannakis C, Cowled PA, Betts WH. Synergy between zinc and phorbol ester in translocation of protein kinase C to cytoskeleton. FEBS Lett 1990;273:131–134.
Knapp LT, Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem 2000;275:24136–24145.
Allen JL, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med 1983;102:577–589.
Keen Cl, Gershwin ME. Zinc deficiency and immune function. Ann Rev Nutr 1990;10:415–431.
Chavakis T, May AE, Preissner KT, Kanse SM. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and b2-integrins. Blood 1999;93:2976–2983.
Hujanen ES, Seppa ST, Virtanen K. Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochem Biophys Acta 1995;1245:145–152.
Prasad AS. Effects of zinc deficiency on immune functions. J Trace Elem Exp Med 2000;13:1–20.
Sohnle PG, Collins-Lech C, Wiessner JH. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis 1991;164:137–142.
Murthy AR, Lehrer RI, Harwig SSI, Miyasaki KT. In vitro candidastic properties of the human neutrophil calprotectin complex. J Immunol 1993;151:6291–6301.
Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defense. Scand J Immunol 1995;42:551–556.
Ravaglia G, Forti P, Maioli F, et al. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects >_ 90 yr. Am J Clin Nutr 2000;71:590–598.
Rajagopalan S, Winter CC, Wagtmann N, Long EO. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol 1995;155:4143–4146.
Prasad AS. Effects of zinc deficiency on Thl and Th2 cytokine shifts. Infect Dis 2000;182(Suppl 1):S62–568.
Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199–210.
Rink L, Seyfarth M. Characteristics of immunologic test values in elderly. Z Gerontol Geriatr 1997;30:220–225.
Ibs KH, Rink L. The immune system of elderly. Z Gerontol Geriatr 2001;34:480–485.
Minigari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T cell responses. Immunol Today 1998;19:153–157.
Mocchegiani E, Santarelli L, Muzzioli M, Fabris N. Reversibility of the thymic involution and agerelated peripheral immune dysfunction by zinc supplementation in old mice. Int J Immunopharmacol 1995;17:703–718.
Dardenne M, Pléaz JM, Nabarra B, et al. Contribution of zinc and other metals to the biological activity of the serum thymic factors. Proc Natl Acad Sci USA 1982;79:5370–5373.
Hadden JW. Thymic endocrinology. Int J Immunopharmacol 1992;14:345–352.
Coto JA, Hadden EM, Sauro M, Zorn N, Hadden JW. Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. Proc Natl Acad Sci USA 1992;89:7752–7756.
Safie-Garabedian B, Ahmed K, Khamashta MA, Taub NA, Hughes GRV. Thymulin modulates cytokine release by peripheral blood mononuclear cells: a comparsion between healthy volunteers and patients with systemic lupus erythrematodes. Int Arch Allergy Immunol 1993;101:126–131.
Tanaka Y, Shiozawa S, Morimoto I, Fujita T. Zinc inhibits pokeweed mitogen-induced development of immunglobulin-secreting cells through augmentation of both CD4 and CD8 cells. Int J Immunopharmacol 1989;11:673–679.
Dowd PS, Kelleher J, Guillou PJ. T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br J Nutr 1986;55:59–69.
Crea A, Guerin V, Ortega F, Hartemann P. Zinc et système immunitaire. Ann Med Intern 1990;141: 447–451.
Fraker PJ, King LE, Garvy BA, Medina CA. The immunopathology of zinc deficiency in humans and rodents: a possible role for programmed cell death. In: Klurfeld DM (ed.). Human Nutrition: A Comprehensive Treatise. Plenum, New York, 1993, pp. 267–283.
Fraker PJ, Osatiashtiani E, Wagner MA, King LE. Possible roles for glucocorticoides and apoptosis in the suppression of lymphopoiesis during zinc deficiency: a review. J Am Coll Nutr 1995;14:11–17.
Fraker PJ, Telford WG. A reappraisal of the role of zinc in life and death decisions of cells. Proc Soc Exp Biol Med 1997;215:229–236.
Zazonico R, Fernandes G, Good RA. The differential sensitivity of T cell and B cell mitogenesis to in vitro Zn deficiency. Cell Immunol 1981;60:203–211.
Flynn A. Control of in vitro lymphocyte proliferation by copper, magnesium and zinc deficiency. J Nutr 1984;114:2034–2042.
Fraker PJ, Jardieu P, Cook J. Zinc deficiency and the immune function. Arch Dermatol Res 1987;123:1699–1701.
King LE, Fraker PJ. Variations in the cell cycle status of lymphopoietic and myelopoietic cells created by zinc deficiency. J Infect Dis 2000;182(Suppl 1):S16-S22.
Fraker PJ, De Pasquale-Jardieu R, Zwickl CM, Luecke RW. Regeneration of T-cell helper function in zinc-deficient adult mice. Proc Natl Acad Sci USA 1978;75:5660–5664.
Fraker PJ. Zinc deficiency: a common state. Sury Immunol Res 1983;2:155–163.
Depasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr 1984;114:1762–1769.
Moulder K, Steward MW. Experimental zinc deficiency: effects on cellular responses and the affinity of humoral antibody. Clin Exp Immunol 1989;77:269–274.
Fraker PJ, Gershwin ME, Good RA, Prasad AS. Interrelationships between zinc and immune function. Fed Proc 1986;45:1474–1479.
Salas M, Kirchner H. Induction of interferon-y in human leukocyte cultures stimulated by Zn2t. Clin Immunol Immunpathol 1987;45:139–142.
Scuderi P. Differential effects of copper and zinc on human peripheral blood monocyte cytokine secretion. Cell Immunol 1990;126:391–405.
Driessen C, Hiry K, Rink L, Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res 1994;14:15–20.
Wellinghausen N, Fischer A, Kirchner H, Rink L. Interaction of zinc ions with human peripheral blood mononuclear cells. Cell Immunol 1996;171:255–261.
Rühl H, Kirchner H. Monocyte-dependent stimulation of human T-cells by zinc. Clin Exp Immunol 1978;32:484–488.
Wellinghausen N, Martin M, Rink L. Zinc inhibits IL-1 dependent T cell stimulation. Eur J Immunol 1997;27:2529–2535.
Hadden JW. The treatment of zinc is an immunotherapy. Int J Immunopharmacol 1995;17:697–701.
Phillips JL, Azari P. Zinc transferring: enhancement of nucleic acid in phytohemagglutinin-stimulated human lymphocytes. Cell Immunol 1974;10:31–37.
Driessen C, Hiry K, Wellinghausen N, Kirchner H, Rink L. Influence of serum on zinc, toxic shock syndrome toxin-1, and lipopolysaccharide-induced production of IFN-γ and IL-1ββ by human mononuclear cells. J Leukoc Biol 1995;57:904–908.
Bulgarini D, Habetswallner D, Boccoli G, et al. Zinc modulates the mitogenic activation of human peripheral blood lymphocytes. Ann Inst Super Sanita 1989;25:463–470.
Goode HF, Kelleher J, Walker BE. Zinc concentrations in pure populations of peripheral blood neutrophils, lymphocytes and monocytes. Ann Clin Biochem 1989;26:85–95.
Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr 1997;66:4605–463S.
Chandra RK. Effects of vitamin and trace-element supplementation on immune responses and infections in the elderly. Lancet 1992;340:1124–1137.
Fortes C, Forastiere F, Agabiti N, et al. The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 1998;46:19–26.
Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990;15:225–227.
Campo CA, Wellinghausen N, Faber C, Fischer A, Rink L. Zinc inhibits the mixed lymphocyte culture. Biol Trace Elem Res 2001;79:15–22.
Cakman I, Kirchner H, Rink L. Reconstitution of interferon-γ production by zinc-supplementation of leukocyte cultures of elderly individuals. J Interferon Cytokine Res 1997;13:15–20.
Provinciali M, Montenovo A, Di-Stefano G, et al. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing 1998;27:715–722.
Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984:252:1443–1446.
Reinhold D, Ansorge S, Grungreiff K. Immunobiology of zinc and zinc therapy. Immunol Today 1999;20:102.
Rink L, Kirchner H. Reply to Reinhold et al. Immunol Today 1999;20:102–103.
Sandstaed HH, Henriksen LK, Greger JL, Prasad AS, Good RA. Zinc nutriture in the elderly in relation to taste acuity, immune response, and wound healing. Am J Clin Nutr 1982;36:1046–1059.
Cakman I, Rohwer J, Schütz RM, Kirchner H, Rink L. Dysregulation between Th 1 and Th2 cell subpopulations in the elderly. Mech Ageing Dev 1996;87:197–209.
Kreft B, Fischer A, Kruger S, Sack K, Kirchner H, Rink L. The impaired immune response to diphtheria vaccination in elderly chronic hemodialysis patients is related to zinc deficiency. Biogerontology 2000;1:61–66.
Brodersen HP, Holtkamp W, Larbig D, et al. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study. Nephrol Dial Transplant 1995;10:1780.
Turk S, Bozfakioglu S, Ecder ST, et al. Effects of zinc supplementation on the immune system and on antibody response to multivalent influenza vaccine in hemodialysis patients. Inter J Atif Organs 1998;21:274–278.
Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN VIT AOX Geriatric network. Arch Intern Med 1999;159:748–754.
Mocchegiani E, Santarelli L, Muzzioli M, Fabris N. Reversibility of the thymic involution and of agerelated peripheral immune dysfunction by zinc supplementation in old mice. Int J Immunopharmacol 1995;17:703–718.
Driessen C, Hiry K, Kirchner H, Rink L. Divergent effects of zinc on different bacterial pathogenic agents. J Infect Dis 1995;171:486–489.
Driessen C, Hiry K, Kirchner H, Rink L. Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 1995;84:272–277.
Wellinghausen N, Schromm AB, Seydel U, et al. Zinc enhances lipopolysaccharide-induced monokine secretion by a fluidity change of lipopolysaccharide. J Immunol 1996;157:3139–3145.
Wellinghausen N, Rink L. The significance of zinc for leukocyte biology. J Leukoc Biol 1998;571–577.
Briefel RR, Bialostoky K, Kennedy-Stephenson J, McDowell MA, Ervin RB, Wright JD. Zinc intake of the U.S. population: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. J Nutr 2000;130:1367–1373.
Bannerman E, Magarey AM, Daniels LA. Evaluation of micronutrient intakes of older Australians: The National Nutrition Survey-1995. J Nutr Health Aging 2001;5:234–247.
Ge KY, Chang SY. Dietary intake of some essential micronutrients in China. Biomed Environ Sci 2001;14:318–324.
Campillo JE, Perez G, Rodriguez A, Torres MD. Vitamins and mineral intake in elderly people from Extremadura. J Nutr Health Aging 2002;6:55–56.
Akhter P, Akram M, Orfi SD, Ahmad N. Assessment of dietary zinc ingestion in Pakistan. Nutrition 2002;18:274–278.
Cupisti A, D’Alessandro C, Castrogiovanni S, Barale A, Morelli E. Nutrition knowledge and dietary composition in Italian adolescent female athletes and non-athletes. Intl Sport Nutr Exerc Metab 2002;12:207–219.
Natera E, Trinidad T, Valdez D, Kawamura H, Palad L, Shiraishi K. Estimation of daily micronutrient intake of Filipinos. Food Nutr Bull 2002;23:222–227.
Thane CW, Bates CJ. Dietary intakes and nutrient status of vegetarian preschool children from a British national survey. J Hum Nutr Diet 2000;13:149–162.
Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 1997;272:E1002–E1007.
Prasad AS. Zinc and immunity. Mol Chem Biochem 1998;188:63–69.
Prasad AS. Zinc: an overview. Nutrition 1995;11:93–99.
Peretz A, Cantinieaux B, Neve J, Sidoerova V, Fondu P. Effects of zinc suppplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases. J Trace Elem Electr Health Dis 1994;8:189–194.
Naveh Y, Schapira D, Ravel Y, Geller E, Scharf Y. Zinc metabolism in rheumatoid arthritis: plasma and urinary zinc and relationship to disease activity. J Rheumatol 1997;24:643–646.
Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976;2:539–542.
Varadinova TL, Bontchev PR, Nachev CK, et al. Mode of action of Zn-complexes on herpes simplex virus type 1 infection in vitro. J Chemother 1993;5:3–9.
Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med 2001;7:49–56.
Trubiani O, Antonucci A, Palka G, Di-Primo R. Programmed cell death of peripheral myeloid precursor cells in Down patients: effect of zinc therapy. Ultrastruct Pathol 1996;20:457–462.
Antonucci A, Di-Baldassarre A, Di-Giacomo F, Stuppia L, Palka G. Detection of apoptosis in peripheral blood cells of 31 subjects affected by Down syndrome before and after zinc therapy. Ultrastruct Pathol 1997;21:449–452.
Krasovec M, Frenk E. Acrodermatitis enteropathica secondary to Crohn’s disease. Dermatology 1996;193:361–363.
Myung SJ, Yang SK, Jung HY, et al. Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn’s disease. J Gastroenterol 1998;33:876–879.
Struniolo GC, Di Leo V, Ferronato A, D’Odorico A, D’Inca R. Zinc supplementation tightens “leaky gut” in Crohn’s disease. Inflamm Bowel Dis 2001;7:94–98.
Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992;71:139–164.
Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y. Treatment of Wilson’s disease with zinc. XIII: therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994;123:849–858.
Struniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D’Inca R. Zinc therapy increases duodenal concentrations of methallothionein and iron in Wilson’s diesease patients. Am J Gastroenterol 1999;94:334–338.
Shimizu N, Yamauchi Y, Aoki T. Treatment and management of Wilson’s disease. Pediatr Intl 1999;41:419–422.
Prasad AS, Beck FW, Kaplan J, et al. Effect of zinc supplementation on incidence of infections and hospital admission in sickle cell disease (SCD). Am J Hematol 1999;61:194–202.
Mossad SB, Macknin ML, Medendrop SV, Mason P. Zinc gluconate lozenges for treating the common cold. Ann Intern Med 1996;125:81–88.
Mocchegiani E, Veccia S, Ancarani F, Scalise G, Fabris N. Benefit of oral zinc supplementation as an adjust to zidovudine (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995;17:719–727.
Wellinghausen N, Kern WV, Jöchle W, Kern P. Zinc serum level in human deficiency virus infected patients in relation to immunological status. Biol Trace Elem Res 2000;73:79–89.
Neves I Jr, Bertho AL, Veloso VG, Nascimento DV, Campos-Mello DL, Morgado MG. Improvement of the lymphoproliferative immune response and apoptosis inhibition upon in vitro treatment with zinc of peripheral blood mononuclear cells (PBMC) from HIV+ individuals. Clin Exp Immunol 1998;111:264–268.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ibs, KH., Rink, L. (2004). Zinc. In: Hughes, D.A., Darlington, L.G., Bendich, A. (eds) Diet and Human Immune Function. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-652-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-652-2_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-422-7
Online ISBN: 978-1-59259-652-2
eBook Packages: Springer Book Archive